Breyanzi Becomes Fourth CAR T-Cell Therapy Reimbursed In England

 
• By Neena Brizmohun
  
3d illustration CAR T-cell attack cancer cell and healthy cells
Breyanzi is a CAR T-cell therapy for patients with large B-cell lymphoma (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Government Payers